DNA
Ginkgo Bioworks Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.80
+0.40 ▲ +6.25%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$6.80
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -5.68 | Insider Own | 24.9% | Shs Outstand | 0.05B | Perf Week | 4.62% |
| Market Cap | 0.42B | Forward P/E | - | EPS next Y | 12.78% | Insider Trans | -0.06% | Shs Float | 0.04B | Perf Month | -27.27% |
| Enterprise Value | 0.43B | PEG | - | EPS next Q | -1.21 | Inst Own | 58.26% | Short Float | 17.08% | Perf Quarter | -30.47% |
| Income | -0.31B | P/S | 2.45 | EPS this Y | 21.53% | Inst Trans | 5.29% | Short Ratio | 6.79 | Perf Half Y | -34.87% |
| Sales | 0.17B | P/B | 0.74 | EPS next 5Y | - | ROA | -25.05% | Short Interest | 7.49M | Perf YTD | -18.17% |
| Book/sh | 9.21 | P/C | 0.97 | EPS past 3/5Y | 51.73% -7.49% | ROE | -51.08% | 52W High | -61.32% ($17.58) | Perf Year | 5.26% |
| Cash/sh | 7 | P/FCF | - | Sales past 3/5Y | -29.11% 17.29% | ROIC | -33.79% | 52W Low | 36% ($5.00) | Perf 3Y | -87.41% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 46.46% | Gross Margin | 40.49% | Volatility(W/M) | 8.11% 8.27% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.51 | Sales Y/Y TTM | -25.06% | Oper. Margin | -184.6% | ATR (14) | 0.71 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.92 | EPS Q/Q | 27.13% | Profit Margin | -183.81% | RSI (14) | 40.97 | Recom | 3.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.92 | Sales Q/Q | -23.84% | SMA20 | -13.08% ($7.82) | Beta | 1.57 | Target Price | $8.5 |
| Payout | - | Debt/Eq | 0.86 | Earnings | 2000000 | SMA50 | -22.12% ($8.73) | Rel Volume | 1.59 | Prev Close | $6.4 |
| Employees | 485 | LT Debt/Eq | 0.82 | EPS/Sales Surpr. | 3.09% -11.03% | SMA200 | -34.57% ($10.39) | Avg Volume(3M) | 1.10M | Price | $6.8 |
| IPO | 2021/4/19 | Option/Short | Yes/Yes | Trades | 10314 | Volume | 1,756,430 | Change | 6.25% |
뉴스 로딩 중...